GRIP1, a Transcriptional Coactivator for the AF-2 Transactivation Domain of Steroid, Thyroid, Retinoid, and Vitamin D Receptors

REFERENCES

• Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403–410.
   PubMed Web of Science ®Google Scholar
• Baker, A. R., D. P. McDonnell, M. Hughes, T. M. Crisp, D. J. Mangelsdorf, M. R. Haussler, J. W. Pike, J. Shine, and B. W. O’Malley. 1988. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc. Natl. Acad. Sci. USA 85:3294–3298.
   PubMed Web of Science ®Google Scholar
• Baniahmad, A., I. Ha, D. Reinberg, S. Tsai, M.-J. Tsai, and B. W. O’Malley. 1993. Interaction of human thyroid hormone receptor β with transcription factor TFIIB may mediate target gene derepression and activation by thyroid hormone. Proc. Natl. Acad. Sci. USA 90:8832–8836.
   PubMedGoogle Scholar
• Beato, M. 1989. Gene regulation by steroid hormones. Cell 56:335–344.
   PubMed Web of Science ®Google Scholar
• Berger, S. L., B. Piña, N. Silverman, G. A. Marcus, J. Agapite, J. L. Regier, S. J. Triezenberg, and L. Guarente. 1992. Genetic isolation of ADA2: a potential transcriptional adaptor required for function of certain acidic activation domains. Cell 70:251–265.
   PubMed Web of Science ®Google Scholar
• Berry, M., D. Metzger, and P. Chambon. 1990. Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J. 9:2811–2818.
   PubMed Web of Science ®Google Scholar
• Burris, T. P., Z. Nawaz, M.-J. Tsai, and B. W. O’Malley. 1995. A nuclear hormone receptor-associated protein that inhibits transactivation by thyroid hormone and retinoic acid receptors. Proc. Natl. Acad. Sci. USA 92:9525–9529.
   PubMedGoogle Scholar
• Cavaillès, V., S. Dauvois, F. L’Horset, G. Lopez, S. Hoare, P. J. Kushner, and M. G. Parker. 1995. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J. 14:3741–3751.
   PubMed Web of Science ®Google Scholar
• Chen, J. D., and R. M. Evans. 1995. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454–457.
   PubMed Web of Science ®Google Scholar
• Chiang, C.-M., and R. G. Roeder. 1995. Cloning of an intrinsic human TFIID subunit that interacts with multiple transcriptional activators. Science 267:531–536.
   PubMed Web of Science ®Google Scholar
• Dalman, F. C., E. H. Bresnick, P. D. Patel, G. H. Perdew, S. J. Watson, Jr., and W. B. Pratt. 1989. Direct evidence that the glucocorticoid receptor binds to hsp90 at or near the termination of receptor translation in vitro. J. Biol. Chem. 264:19815–19821.
   PubMedGoogle Scholar
• Danielian, P. S., R. White, J. A. Lees, and M. G. Parker. 1992. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J. 11:1025–1033.
   PubMed Web of Science ®Google Scholar
• Devereux, J., P. Haeberli, and O. Smithies. 1984. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 12:387–395.
   PubMed Web of Science ®Google Scholar
• El-Ashry, D., S. A. Oñate, S. K. Nordeen, and D. P. Edwards. 1989. Human progesterone receptor complexed with the antagonist RU486 binds to hormone response elements in a structurally altered form. Mol. Endocrinol. 3:1545–1558.
   PubMedGoogle Scholar
• Evans, R. M. 1988. The steroid and thyroid hormone receptor superfamily. Science 240:889–895.
   PubMed Web of Science ®Google Scholar
• Garabedian, M. J. 1993. Genetic approaches to mammalian nuclear receptor function in yeast. Methods (Orlando) 5:138–146.
   Google Scholar
• Garabedian, M. J., and K. R. Yamamoto. 1992. Genetic dissection of the signaling domain of a mammalian steroid receptor in yeast. Mol. Biol. Cell 3:1245–1257.
   PubMed Web of Science ®Google Scholar
• Goodrich, J. A., and R. Tjian. 1994. TBP-TAF complexes: selectivity factors for eukaryotic transcription. Curr. Opin. Cell Biol. 6:403–409.
   PubMedGoogle Scholar
• Hollenberg, S. M., and R. M. Evans. 1988. Multiple and cooperative trans-activation domains of the human glucocorticoid receptor. Cell 55:899–906.
   PubMed Web of Science ®Google Scholar
• Hong, H., K. Kohli, A. Trivedi, D. L. Johnson, and M. R. Stallcup. 1996. GRIP1, a novel mouse protein that serves as a transcriptional co-activator in yeast for the hormone binding domains of steroid receptors. Proc. Natl. Acad. Sci. USA 93:4948–4952.
   PubMedGoogle Scholar
• Horwitz, K. B., T. A. Jackson, D. L. Bain, J. K. Richer, G. S. Takimoto, and L. Tung. 1996. Nuclear receptor coactivators and corepressors. Mol. Endo-crinol. 10:1167–1177.
   PubMed Web of Science ®Google Scholar
• Ing, N. H., J. M. Beekman, S. Y. Tsai, M.-J. Tsai, and B. W. O’Malley. 1992. Members of the steroid hormone receptor superfamily interact directly with TFIIB (S300II) to mediate transcriptional induction. J. Biol. Chem. 267:17617–17623.
   PubMedGoogle Scholar
• Jacq, X., C. Brou, Y. Lutz, I. Davidson, P. Chambon, and L. Tora. 1994. Human TAFII30 is present in a distinct TFIID complex and is required for transcriptional activation by estrogen receptor. Cell 79:107–117.
   PubMedGoogle Scholar
• Kamei, Y., L. Xu, T. Heinzel, J. Torchia, R. Kurokawa, B. Gloss, S.-C. Lin, R. A. Heyman, D. W. Rose, C. K. Glass, and M. G. Rosenfeld. 1996. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403–414.
   PubMed Web of Science ®Google Scholar
• Kurokawa, R., M. Söderström, A. Hörlein, S. Halachmi, M. Brown, M. G. Rosenfeld, and C. K. Glass. 1995. Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature 377:451–454.
   PubMed Web of Science ®Google Scholar
• Kwok, R. P. S., J. R. Lundblad, J. C. Chrivia, J. P. Richards, H. P. Bächinger, R. G. Brennan, S. G. E. Roberts, M. R. Green, and R. H. Goodman. 1994. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 370:223–229.
   PubMed Web of Science ®Google Scholar
• Le Douarin, B., C. Zechel, J.-M. Garnier, Y. Lutz, L. Tora, B. Pierrat, D. Heery, H. Gronemeyer, P. Chambon, and R. Losson. 1995. The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J. 14:2020–2033.
   PubMed Web of Science ®Google Scholar
• Lees, J. A., S. E. Fawell, and M. G. Parker. 1989. Identification of two transactivation domains in the mouse oestrogen receptor. Nucleic Acids Res. 17:5477–5489.
   PubMed Web of Science ®Google Scholar
• Mangelsdorf, D. J., and R. M. Evans. 1995. The RXR heterodimers and orphan receptors. Cell 83:841–850.
   PubMed Web of Science ®Google Scholar
• McDonnell, D. P. Personal communication.
   Google Scholar
• McDonnell, D. P., D. L. Clemm, T. Hermann, M. E. Goldman, and J. W. Pike. 1995. Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Mol. Endocrinol. 9:659–669.
   PubMed Web of Science ®Google Scholar
• Metzger, D., R. Losson, J.-M. Bornert, Y. Lemoine, and P. Chambon. 1992. Promoter specificity of the two transcriptional activation functions of the human oestrogen receptor in yeast. Nucleic Acids Res. 20:2813–2817.
   PubMedGoogle Scholar
• Milhon, J., K. Kohli, and M. R. Stallcup. 1994. Genetic analysis of the N-terminal end of the glucocorticoid receptor hormone binding domain. J. Steroid Biochem. Mol. Biol. 51:11–19.
   PubMedGoogle Scholar
• Misrahi, M., M. Atger, L. d’Auriol, H. Loosfelt, C. Meriel, F. Fridlansky, A. Guiochon-Mantel, F. Galibert, and E. Milgrom. 1987. Complete amino acid sequence of the human progesterone receptor deduced from cloned cDNA. Biochem. Biophys. Res. Commun. 143:740–748.
   PubMed Web of Science ®Google Scholar
• Oñate, S. A., S. Y. Tsai, M.-J. Tsai, and B. W. O’Malley. 1995. Sequence and characterization of a coactivator for the steroid hormone receptor super-family. Science 270:1354–1357.
   PubMed Web of Science ®Google Scholar
• Patel, P. D., T. G. Sherman, D. J. Goldman, and S. J. Watson. 1989. Molecular cloning of a mineralocorticoid (type I) receptor complementary DNA from rat hippocampus. Mol. Endocrinol. 3:1877–1885.
   PubMedGoogle Scholar
• Printen, J. A., and G. F. Sprague. 1994. Protein-protein interactions in the yeast pheromone response pathway: Ste5p interacts with all members of the MAP kinase cascade. Genetics 138:609–619.
   PubMedGoogle Scholar
• Sadovsky, Y., P. Webb, G. Lopez, J. D. Baxter, P. M. Fitzpatrick, E. Gizang-Ginsberg, V. Cavaillès, M. G. Parker, and P. J. Kushner. 1995. Transcrip-tional activators differ in their responses to overexpression of TATA-box-binding protein. Mol. Cell. Biol. 15:1554–1563.
   PubMedGoogle Scholar
• Sauer, F., S. K. Hansen, and R. Tjian. 1995. Multiple TAFIIs directing synergistic activation of transcription. Science 270:1783–1788.
   PubMed Web of Science ®Google Scholar
• Schena, M., L. P. Freedman, and K. R. Yamamoto. 1989. Mutations in the glucocorticoid receptor zinc finger region that distinguish interdigitated DNA binding and transcriptional enhancement activities. Genes Dev. 3:1590–1601.
   PubMed Web of Science ®Google Scholar
• Schulman, I. G., D. Chakravarti, H. Juguilon, A. Romo, and R. M. Evans. 1995. Interactions between the retinoid X receptor and a conserved region of the TATA-binding protein mediate hormone-dependent transactivation. Proc. Natl. Acad. Sci. USA 92:8288–8292.
   PubMedGoogle Scholar
• Strubin, M., J. W. Newell, and P. Matthias. 1995. OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer-binding proteins. Cell 80:497–506.
   PubMed Web of Science ®Google Scholar
• Tsai, M.-J., and B. W. O’Malley. 1994. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63:451–486.
   PubMed Web of Science ®Google Scholar
• Tzukerman, M. T., A. Esty, D. Santiso-Mere, P. Danielian, M. G. Parker, R. B. Stein, J. W. Pike, and D. P. McDonnell. 1994. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol. Endocrinol. 8:21–30.
   PubMed Web of Science ®Google Scholar
• Voegel, J. J., M. J. S. Heine, C. Zechel, P. Chambon, and H. Gronemeyer. 1996. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J. 15:3667–3675.
   PubMed Web of Science ®Google Scholar
• Walfish, P. G., T. Yoganathan, Y.-F. Yang, H. Hong, T. R. Butt, and M. R. Stallcup. Yeast hormone response element-assays detect and characterize mouse GRIP1 coactivator dependent activation of thyroid and retinoid nuclear receptors. Proc. Natl. Acad. Sci. USA, in press.
   Google Scholar
• Weigel, N. L., C. A. Beck, P. A. Estes, P. Prendergast, M. Altmann, K. Christensen, and D. P. Edwards. 1992. Ligands induce conformational changes in the carboxy-terminus of progesterone receptors which are detected by a site-directed antipeptide monoclonal antibody. Mol. Endocrinol. 6:1585–1597.
   PubMedGoogle Scholar
• Yeh, S., and C. Chang. 1996. Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells. Proc. Natl. Acad. Sci. USA 93:5517–5521.
   PubMed Web of Science ®Google Scholar
• Zhang, S., and M. Danielsen. 1995. Selective effects of 8-Br-cAMP on agonists and antagonists of the glucocorticoid receptor. Endocrine 3:5–12.
   PubMedGoogle Scholar